Dr Sam Hollingworth


Many counties have committed to the Sustainable Development Goals (SDGs): 3.8 says “achieve universal health coverage, including financial risk protection, access to quality essential healthcare services and access to safe, effective, quality and affordable essential medicines and vaccines for all.”  So, how do you do this, especially in low and middle-income countries (LMIC) where there are fewer resources? Many countries have started (or are working towards) national health insurance schemes (like Medicare in Australia) which provides subsidised services and medicines for their population. Health technology assessment (HTA) is the process to make evidence-based decision about how best to spend public monies. This is especially important in the context of declining donor funding. This seminar will profile the work in Ghana of the International Decision Support Initiative (idsihealth.org) - a global network of health, policy and economic expertise focussed on increasing the value and impact of health spending. Ghana is a country on the Gulf of Guinea in West Africa and is a beacon for HTA in sub-Saharan Africa.

Speaker bio:

Dr Sam HollingworthDr Sam Hollingworth is an academic at the School of Pharmacy at the University of Queensland. She has an honorary appointment at Imperial College London (sabbatical in 2018). Her research focuses on medicines and health systems. She works with an extensive network of clinicians and health professionals to investigate the use of medicines and adverse effects in cancer, psychiatry, neurology, internal medicine, and general practice. Sam works on economic evaluations and health technology assessment (HTA). She has an active interest in health systems and health services research, with a particular focus on low and middle-income countries (LMIC) and non-communicable diseases (NCD).Sam worked as a consultant in HTA in Australia for many years evaluating submissions to subsidise medicines on the Pharmaceutical Benefits Scheme (PBS). She has worked on international health projects in Indonesia and is currently working on several HTA projects in Ghana.

Sam coordinates, lectures, and tutors in undergraduate and postgraduate programs. She is an advisor on diverse PhD and student research projects. Sam has studied and worked in Brisbane (UQ), London (Imperial College), Melbourne (Monash), Toronto (Mt Sinai Hospital), and Kumasi, Ghana (Kwame Nkrumah University of Science and Technology).

About Seminar Series

The School of Pharmacy Seminar Series involves regular formal presentations of high-quality scholarly work with broad appeal.

The wider School community is invited to attend, including academic and professional staff, special guests, visitors, as well as HDR, postgraduate, masters and honours students.

Seminars are held on Fridays from 12pm–1pm in room 5034 in the Pharmacy Australia Centre of Excellence, 20 Cornwall St Woolloongabba (next to TRI and the PA Hospital).

Confirmed 2021 seminars

Date Presenter
12-1pm, Friday 19 March
(PACE R5034 and Zoom)
Professor Paul Clarke, Director Diamantina Institute        
12-1pm, Friday 16 April
(Zoom only)
Associate Professor Francine Marques, Monash University     
12-1pm, Friday 23 April
(Zoom only)
Associate Professor Ben Colagiuri, Sydney University 
12-1pm, Friday 7 May
(Zoom only)
Dr Laurence Cheung, Curtin University
12-1pm, Friday 30 July
(location TBC)
Dr Gary Chan, UQ CYSUR
12-1pm, Friday 13 August
(Zoom only)
Professor Sanjay Garg, University of South Australia
12-1pm, Friday 3 September
(PACE R5034 and Zoom)
Associate Professor Michael Barras, UQ Pharmacy
12-1pm 10 September
(Online via Zoom)

Professor Josephine Forbes, Mater Research


12-1pm, Friday 17 September
(PACE R5034 and Zoom)

Professor Nigel McMillan, Program Director: Infectious Diseases and Immunology, Menzies Health Institute QLD, Griffith University

12-1pm, Friday 24 September
(Location TBC)
Denuja Karunakaran, IMB Fellow, Institute for Molecular Bioscience (IMB), UQ


Pharmacy Australia Centre of Excellence, 20 Cornwall St, Woolloongabba